Benzinga's Top #PreMarket Gainers By: Benzinga via Benzinga September 08, 2015 at 08:15 AM EDT Immunomedics, Inc. (NASDAQ: IMMU) shares rose 29.77 percent to $2.79 in pre-market trading following announcement of interim Phase 2 ... Read More >> Related Stocks: Achison Inc Endocyte Inc Immunomedics Inc TECO Energy Tower Semiconductor